OpenVSafe by OpenVAERS
Search V-safe

36X-67779-23185

2 vaccinations 2 coded responses 23 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
606 / IL
Registered
2020-12-23
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
1545661 (opens in a new window) high 9 / 11 2 1 of 7 VAERS symptoms same dose (2) IL matches 2021-01-11 / 2021-06-21 / 2021-08-11
received the same day as the last call
 case 855217

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2020-12-23
    Registered in v-safe
  3. 2020-12-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  4. 2020-12-24
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Abdominal pain
    Adult check-in
  5. 2020-12-25
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  6. 2020-12-26
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  7. 2020-12-27
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  8. 2020-12-28
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-05
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-11
    Dose 2 — Pfizer-BioNTech
  11. 2021-01-11
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  12. 2021-01-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · Joint pains, Muscle or body aches
    Adult check-in
  13. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  14. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Joint pains, Fatigue or tiredness
    Adult check-in
  15. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  17. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache
    Adult check-in
  18. 2021-01-18
    Health check-in — day 7, dose 2
    Feeling: Good · Diarrhea
    Adult check-in
  19. 2021-01-25
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-02-02
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-08
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-02-22
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-12
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-14
    Survey response — 6 months, dose 2
    MedDRA: Sinusitis bacterial — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Acute bacterial sinusitis after exposure to children with RSV
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  26. 2021-07-14
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-07-21
  28. 2021-08-11
    Call successful
    Completed over the phone
  29. 2022-01-11
    Survey response — 12 months, dose 2
    MedDRA: Headache, Nasal congestion — Feeling: Good
    Free text: Nasal Congestion, headache
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-11Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-07-14 Successful
2021-08-11
 Completed over the phone

Free text

Release 9 — 6 months, dose 2

2021-07-14

Symptoms: Acute bacterial sinusitis after exposure to children with RSV

Release 10 — 12 months, dose 2

2022-01-11

Symptoms: Nasal Congestion, headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDHeadache · · ✓
SDNasal congestion · · ✓
SDSinusitis bacterial ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…